Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation.
about
Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trendsClinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patientsMolecular pathogenesis and mechanisms of thyroid cancerLow VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma.Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.Relationship between VEGF protein expression and lymph node metastasis in papillary thyroid carcinoma among Asians: a meta-analysis.Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical TumorsThe prognostic value of regional lymph node metastases in patients of Guangdong Province, China with differentiated thyroid cancer: A multicenter retrospective clinical study.Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma.Leiomyosarcoma of the thyroid gland: A case report and literature review.Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis.Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.Targeting histone deacetylase in thyroid cancer.The role of surgery in the current management of differentiated thyroid cancer.Sunitinib for the treatment of thyroid cancer.Diagnostic and prognostic markers in differentiated thyroid cancer.
P2860
Q26749311-97C8B32E-9704-4FCE-851E-6C0B5D7967A6Q28077406-69678AAA-DEC1-48A0-8448-F2581D2A0A48Q34329018-357C9CA4-B65A-4012-B01E-9EFFF5E47990Q34662980-0B5DB2AD-8F96-407D-9A8C-EEC11DE5E76BQ35051184-658EC6CB-0699-4853-8497-A509EDEE09C0Q35099272-BDB70CA2-C8C0-410D-8EE5-EFEBE1584E1BQ36240937-A6FC4F89-6004-4396-B0DA-A9CE20EFE0F9Q37354766-004726ED-F5AD-4DEB-9D95-E81F4F081E97Q37650615-1879292D-0398-4F19-940E-34FD01E2664BQ37652429-05091D3B-A3B0-4ADB-9418-14E27277688BQ37721103-FB601A1A-9980-4D92-A299-3B028CBF8A7DQ37920474-CB15205F-5548-4CDB-ABAB-50919671F71CQ38066990-087CC6E5-F99F-4083-B4F0-34BD39823A94Q38203464-66B03A4A-5B06-4F8A-AE7D-9542B6C21F5CQ38966228-95BE8BBD-74EB-4E26-99D1-A2E6AAE2B10FQ40819992-837B4AF5-4860-4015-A46E-3D017697FD11
P2860
Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Upregulation of endocrine glan ...... metastases, and BRAF mutation.
@ast
Upregulation of endocrine glan ...... metastases, and BRAF mutation.
@en
type
label
Upregulation of endocrine glan ...... metastases, and BRAF mutation.
@ast
Upregulation of endocrine glan ...... metastases, and BRAF mutation.
@en
prefLabel
Upregulation of endocrine glan ...... metastases, and BRAF mutation.
@ast
Upregulation of endocrine glan ...... metastases, and BRAF mutation.
@en
P2093
P356
P1433
P1476
Upregulation of endocrine glan ...... metastases, and BRAF mutation.
@en
P2093
Andrea Renzullo
Angela Santoro
Antonio Bellastella
Daniela Pasquali
Giacomo Accardo
Giovanni Conzo
Giuseppe Pannone
Pantaleo Bufo
Valentina Sacco
William J Deery
P304
P356
10.1089/THY.2010.0168
P577
2011-04-01T00:00:00Z